| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |